Protective effect of pravastatin on vascular endothelium in patients with systemic sclerosis: a pilot study

Ann Rheum Dis. 2006 Aug;65(8):1118-20. doi: 10.1136/ard.2005.046870.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Aged
  • Antithrombin III / analysis
  • Biomarkers / blood
  • Case-Control Studies
  • Endothelium, Vascular / metabolism*
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Male
  • Middle Aged
  • Peptide Hydrolases / analysis
  • Pilot Projects
  • Pravastatin / therapeutic use*
  • Scleroderma, Systemic / drug therapy*
  • Scleroderma, Systemic / metabolism
  • von Willebrand Factor / analysis

Substances

  • Biomarkers
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • antithrombin III-protease complex
  • von Willebrand Factor
  • Antithrombin III
  • Peptide Hydrolases
  • Pravastatin